- Novartis India’s net profit rose 16.7% to Rs 32.2 crore in Q1 year-on-year
- Revenue from operations increased 18.7% to Rs 104 crore in the June quarter
- EBITDA jumped 29.2% to Rs 35 crore, showing faster growth than revenue
Novartis India Ltd. reported a healthy set of numbers for the June quarter, with net profit, revenue and operating earnings all registering double-digit growth from the year-ago period.
The pharmaceutical company's net profit rose 16.7% year-on-year to Rs 32.2 crore in the first quarter, compared with Rs 27.6 crore reported in the corresponding period last year.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
Revenue from operations increased 18.7% to Rs 104 crore during the quarter under review, from Rs 87.6 crore in the same quarter of the previous financial year.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
Investors will be tracking the stock following the improvement in profitability and margins during the quarter.
Operating Profit Rises 29%
Novartis India's operating performance improved at a faster pace than its topline during the June quarter.
Earnings before interest, taxes, depreciation and amortisation (Ebitda) jumped 29.2% year-on-year to Rs 35 crore. The company had reported Ebitda of Rs 27.1 crore in the corresponding quarter last year.
The stronger growth in operating profit also resulted in an expansion in the company's Ebitda margin.
Ebitda margin stood at 33.7% for the quarter, up from 30.9% in the year-ago period. That represents an improvement of 280 basis points year-on-year.
Stock price performance
Shares of Novartis India Ltd. were trading at Rs 1,680 apiece on NSE, marginally down by 1% from its previous close at Rs 1,699.8, even after the company reported healthy first quarter results.
Having said that, the stock has been rallying since the beginning of 2026, gaining more than 66% during the period, and has gained over 12.5% during the past month itself.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
